RxDestruct Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Private

  • Employees
  • 6


  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $2.45M

  • Investors
  • 6

RxDestruct General Information


Developer of a waste management device designed to help hospitals and nursing homes to dispose off their pharmaceutical waste safely and conveniently. The company's product helps in neutralizing the active compounds in unused medications so they can be disposed of easily without polluting water supplies, enabling hospitals to ensure pharmaceutical waste stays out of the environment and does not contribute to the current opioid epidemic sweeping.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Environmental Services (B2B)
Other Industries
Medical Supplies
Corporate Office
  • 3410 Onion Creek
  • Sugar Land, TX 77479
  • United States
+1 (832) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

RxDestruct Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series A) 03-Jun-2020 $2.45M 00.000 00.000 Completed Generating Revenue
3. Angel (individual) 24-Oct-2013 00000 Completed Startup
2. Angel (individual) 14-Nov-2011 $342K $342K Completed Startup
1. Accelerator/Incubator Completed Startup
To view RxDestruct’s complete valuation and funding history, request access »

RxDestruct Cap Table

Stock # of Shares
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000,000 00.000000 00.00 00 00 00 00 00.000
To view RxDestruct’s complete cap table history, request access »

RxDestruct Executive Team (3)

Name Title Board Seat Contact Info
Mark Macdonell Chief Executive Officer & Board Member
You’re viewing 1 of 3 executive team members. Get the full list »

RxDestruct Board Members (6)

Name Representing Role Since
Chris Quinn Self Board Member 000 0000
Mark Macdonell RxDestruct Chief Executive Officer & Board Member 000 0000
Michael Sanborn Self Board Member 000 0000
Scott Kosch Self Board Member 000 0000
You’re viewing 4 of 6 board members. Get the full list »

RxDestruct Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

RxDestruct Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Cascata Capital Management PE/Buyout Minority 000 0000 000000 0
i2E Not-For-Profit Venture Capital Minority 000 0000 000000 0
Plains Ventures Venture Capital Majority 000 0000 000000 0
SeedStep Angels Angel Group Minority 000 0000 000000 0
Scott Kosch Angel (individual) Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

RxDestruct FAQs

  • When was RxDestruct founded?

    RxDestruct was founded in 2009.

  • Who is the CEO of RxDestruct?

    Mark Macdonell is the CEO of RxDestruct.

  • Where is RxDestruct headquartered?

    RxDestruct is headquartered in Sugar Land, TX.

  • What is the size of RxDestruct?

    RxDestruct has 6 total employees.

  • What industry is RxDestruct in?

    RxDestruct’s primary industry is Environmental Services (B2B).

  • Is RxDestruct a private or public company?

    RxDestruct is a Private company.

  • What is the current valuation of RxDestruct?

    The current valuation of RxDestruct is 00.000.

  • What is RxDestruct’s current revenue?

    The current revenue for RxDestruct is 000000.

  • How much funding has RxDestruct raised over time?

    RxDestruct has raised $2.79M.

  • Who are RxDestruct’s investors?

    Cascata Capital Management, i2E, Plains Ventures, SeedStep Angels, and Scott Kosch are 5 of 6 investors who have invested in RxDestruct.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »